Alexander RK, Liou YH, Knudsen NH, Starost KA, Xu C, Hyde AL, et al. Bmal1 integrates mitochondrial metabolism and macrophage activation. Elife. 2020. https://doi.org/10.7554/eLife.54090.

Article  PubMed  PubMed Central  Google Scholar 

Badar W, Cooper EG, Florido CR, Rabaza M, Sheikh U, Guzman G, et al. Comparative radiologic response assessment after transarterial chemoembolization, percutaneous ablation, and multimodal treatment: radiologic-pathologic correlation in 81 tumors. J Vasc Interv Radiol. 2025;36:961–70. https://doi.org/10.1016/j.jvir.2025.02.016.

Article  PubMed  Google Scholar 

Balaji N, Kukal S, Bhat A, Pradhan N, Minocha S, Kumar S. A quartet of cancer stem cell niches in hepatocellular carcinoma. Cytokine Growth Factor Rev. 2024;79:39–51. https://doi.org/10.1016/j.cytogfr.2024.08.007.

Article  CAS  PubMed  Google Scholar 

Blair S, Newcomer J, Raissi D. Microwave ablation for hepatocellular carcinoma in cirrhotic patients with diuretic-resistant ascites. J Clin Imaging Sci. 2025;15:33. https://doi.org/10.25259/jcis_11_2025.

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Cai H, Dai X, Guo X, Zhang L, Cao K, Yan F, et al. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma. Acta Biomater. 2021;127:276–86. https://doi.org/10.1016/j.actbio.2021.03.051.

Article  CAS  PubMed  Google Scholar 

Canale M, Foschi FG, Andreone P, Ercolani G, Marisi G, Conti F, et al. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery. HPB (Oxford). 2022;24:244–54. https://doi.org/10.1016/j.hpb.2021.06.421.

Article  PubMed  Google Scholar 

Canale M, Ulivi P, Foschi FG, Scarpi E, De Matteis S, Donati G, et al. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. Crit Rev Oncol Hematol. 2018;129:44–53. https://doi.org/10.1016/j.critrevonc.2018.06.017.

Article  PubMed  Google Scholar 

Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC). Cancers (Basel). 2022;14. https://doi.org/10.3390/cancers14112798

Chen J, Pang J, Wen D, Huang F, He Y, Yang H, et al. Post-ablation recurrence in hepatocellular carcinoma: molecular pathogenesis and targeted therapeutic innovations. Am J Cancer Res. 2025;15:4845–56. https://doi.org/10.62347/hflg3477.

Article  PubMed  PubMed Central  Google Scholar 

Chen K, Wang J, Jiang L, Zhao F, Zhang R, Wu Z, et al. A blood hepatocellular carcinoma signature recognizes very small tumor nodules with metastatic traits. J Clin Transl Hepatol. 2024a;12:551–61. https://doi.org/10.14218/jcth.2023.00559.

Article  PubMed  PubMed Central  Google Scholar 

Chen R, Lin Z, Shen S, Zhu C, Yan K, Suo C, et al. Citrullination modulation stabilizes HIF-1alpha to promote tumour progression. Nat Commun. 2024b;15:7654. https://doi.org/10.1038/s41467-024-51882-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Zhang S, Wang Z, Wang F, Cao X, Wu Q, et al. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. J Exp Clin Cancer Res. 2018;37:128. https://doi.org/10.1186/s13046-018-0787-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiang J, Raman SS, Ramakrishnan A, Keshavarz P, Sayre JW, McWilliams JP, et al. Correlation of needle biopsy-acquired histopathologic grade of hepatocellular carcinoma with outcomes after thermal ablation. J Vasc Interv Radiol. 2025;36:50–7. https://doi.org/10.1016/j.jvir.2024.09.008.

Article  PubMed  Google Scholar 

Cho HJ, Kim JK, Nam JS, Wang HJ, Lee JH, Kim BW, et al. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. Clin Biochem. 2015;48:1073–8. https://doi.org/10.1016/j.clinbiochem.2015.06.019.

Article  CAS  PubMed  Google Scholar 

Cho HJ, Kim SS, Nam JS, Kim JK, Lee JH, Kim B, et al. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment. Clin Res Hepatol Gastroenterol. 2017;41:181–9. https://doi.org/10.1016/j.clinre.2016.09.011.

Article  CAS  PubMed  Google Scholar 

Cogliati B, Yashaswini CN, Wang S, Sia D, Friedman SL. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol. 2023;20:647–61. https://doi.org/10.1038/s41575-023-00821-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colaianni F, Zelli V, Compagnoni C, Miscione MS, Rossi M, Vecchiotti D, et al. Role of circulating microRNAs in liver disease and HCC: focus on miR-122. Genes. 2024. https://doi.org/10.3390/genes15101313.

Article  PubMed  PubMed Central  Google Scholar 

Conway JW, Braden J, Wilmott JS, Scolyer RA, Long GV, da Pires Silva I. The effect of organ-specific tumor microenvironments on response patterns to immunotherapy. Front Immunol. 2022;13:1030147. https://doi.org/10.3389/fimmu.2022.1030147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14:4294. https://doi.org/10.1038/s41467-023-39762-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cushing VI, McGeoch AJS, Williams SL, Roumeliotis TI, Feng J, Dan LM, et al. Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase. Science. 2025. https://doi.org/10.1126/science.adw0053.

Article  PubMed  PubMed Central  Google Scholar 

Dai H, Jia G, Wang H, Yang J, Jiang H, Chu M. Epidermal growth factor receptor transactivation is involved in the induction of human hepatoma SMMC7721 cell proliferation by insufficient radiofrequency ablation. Oncol Lett. 2017;14:2463–7. https://doi.org/10.3892/ol.2017.6463.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q, et al. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 2021;11:3489–501. https://doi.org/10.7150/thno.54648.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daly LA, Brownridge PJ, Batie M, Rocha S, Sée V, Eyers CE. Oxygen-dependent changes in binding partners and post-translational modifications regulate the abundance and activity of HIF-1α/2α. Sci Signal. 2021. https://doi.org/10.1126/scisignal.abf6685.

Article  PubMed  Google Scholar 

Deng Q, Chen S, Fu C, Jiang J, Zou M, Tan Y, et al. Long noncoding RNA expression profiles in sub-lethal heat-treated hepatoma carcinoma cells. World J Surg Oncol. 2017;15:136. https://doi.org/10.1186/s12957-017-1194-4.

Article  PubMed  PubMed Central  Google Scholar 

Dohi C, Nouso K, Miyahara K, Morimoto Y, Wada N, Kinugasa H, et al. Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. Hepatol Res. 2016;46:916–23. https://doi.org/10.1111/hepr.12636.

Article  CAS  PubMed  Google Scholar 

Dong S, Kong J, Kong F, Kong J, Gao J, Ke S, et al. Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. J Transl Med. 2013;11:273. https://doi.org/10.1186/1479-5876-11-273.

Article  CAS  PubMed